- Report
- February 2021
Global
From €2846EUR$2,960USD£2,442GBP
- Report
- January 2023
- 97 Pages
Global
From €3361EUR$3,495USD£2,883GBP
- Report
- November 2022
- 1018 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- April 2023
- 103 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- July 2018
- 199 Pages
Global
From €21154EUR$22,000USD£18,147GBP
- Drug Pipelines
- June 2020
- 1855 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- February 2020
- 49 Pages
Global
From €3841EUR$3,995USD£3,295GBP
- Report
- June 2023
- 235 Pages
China
From €3846EUR$4,000USD£3,299GBP
- Report
- June 2023
- 66 Pages
China
From €1731EUR$1,800USD£1,485GBP
- Report
- October 2023
- 101 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- September 2023
- 89 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- September 2023
- 115 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- August 2023
- 91 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- January 2021
- 142 Pages
China, Global
From €3000EUR$3,342USD£2,664GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- February 2024
- 95 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- August 2023
- 77 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- June 2021
- 100 Pages
Global
From €3200EUR$3,565USD£2,841GBP
The Bladder Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat bladder cancer. Bladder cancer is a type of cancer that affects the urinary tract and is the sixth most common type of cancer in the United States. Common treatments for bladder cancer include chemotherapy, radiation therapy, and surgery.
Drugs used to treat bladder cancer are typically classified as either targeted therapies or immunotherapies. Targeted therapies are designed to target specific molecules or pathways in the body that are involved in the growth and spread of cancer cells. Immunotherapies are designed to stimulate the body’s own immune system to fight cancer cells.
Some of the major companies in the Bladder Cancer Drugs market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development and sale of drugs used to treat bladder cancer. Show Less Read more